Thymosin Alpha-1
Category
Immune / Longevity
Frequency
Twice weekly
Research
Clinical (Approved in Asia/Europe)
What is Thymosin Alpha-1
You know the feeling. Every cold that goes around the office finds you. Every flight leaves you with a sore throat. You have read about immune peptides online and now you want to know what Thymosin Alpha-1 actually does and whether it makes sense for someone living in the Philippines.
Thymosin Alpha-1, often abbreviated TA-1, is a 28-amino acid peptide fragment of prothymosin alpha. It is naturally produced by your thymus gland, the small organ behind your breastbone that trains your T-cells. As you age, your thymus shrinks, and TA-1 production declines with it. The synthetic version is called thymalfasin, sold under the brand name Zadaxin in some Asian and European countries.
TA-1 was first sequenced in 1977 by Allan Goldstein at George Washington University. It has been used clinically for hepatitis B and C treatment in parts of Asia and Europe for decades. The mechanism is not immune suppression, it is immune regulation. TA-1 helps your immune system function more effectively without overstimulating it. Browse our full peptide library for related compounds.
In Philippines, TA-1 access is mainly through research-grade suppliers or international hospitals with hepatology departments. Zadaxin is not commonly stocked at standard pharmacies. Most expats sourcing TA-1 go through research-grade peptide suppliers or order from regional sources. For information on how this works, see the peptide legality guide.
How it works
Toll-Like Receptor Activation: TA-1 acts on TLR-2 and TLR-9 on dendritic cells and myeloid cells. This primes your innate immune system to recognize and respond to pathogens more effectively.
T-Cell Maturation: TA-1 stimulates the maturation of T-cells, specifically CD4+ helper T-cells and CD8+ cytotoxic T-cells. This is the same function your thymus performs naturally when it is healthy.
Natural Killer Cell Activation: TA-1 enhances the activity of NK cells, your first line of defense against virally infected cells and early-stage cancer cells.
Cytokine Modulation: TA-1 reduces the production of pro-inflammatory cytokines like IL-1 beta and TNF-alpha while promoting balanced immune signaling. This is regulation, not suppression.
Reported benefits
- 01Enhanced immune response to chronic viral infections (hepatitis B/C, HPV, CMV)
- 02Support for aging immune systems (immunosenescence)
- 03Adjunct therapy potential for autoimmune conditions
- 04Post-illness recovery support
- 05Cancer adjunct in clinical settings (with oncologist oversight)
- 06Reduced frequency of respiratory infections in some users
- 07Improved vaccine response in immunocompromised patients
Dosing protocol
| Phase | Dose | Frequency | Duration |
|---|---|---|---|
| Standard Protocol | 1.5 mg | Twice weekly (sub-q) | 4-12 weeks |
| Acute Support | 0.45 mg | Daily (sub-q) | 2-4 weeks |
| Maintenance | 1.5 mg | Once weekly | Ongoing as needed |
| Clinical (Hepatitis) | 1.6 mg | Twice weekly | 6-12 months |
Always start at the lowest effective dose and titrate up gradually.
Side effects
Common
- Mild injection site reaction (redness, minor swelling)
- Temporary fatigue in first few doses
- Mild headache reported by some users
Rare
- ·Temporary elevation in ALT liver enzymes (monitor if concerned)
- ·Flu-like symptoms during initial immune activation
Who should not use Thymosin Alpha-1
What to expect
Week 1-2
Most users feel nothing dramatic. Some report mild fatigue or flu-like symptoms as immune system activates. This typically resolves within days.
Week 3-4
Users focused on chronic infection support may notice subtle improvements. Energy levels often stabilize. Some report feeling "less susceptible" to whatever is going around.
Week 5-8
Cumulative immune benefits become more apparent. Users with chronic viral loads may see improvements in relevant bloodwork. General resilience improves.
Week 8+
Most users complete a cycle and assess. Some continue maintenance dosing. Others cycle off and return seasonally or when immune challenges arise.
FAQ
Is Thymosin Alpha-1 legal in the Philippines?
TA-1 exists in a gray area similar to most research peptides in the Philippines. Zadaxin is approved in several Asian countries for hepatitis treatment, but not specifically registered with the FDA in the Philippines. Most users source research-grade TA-1 from regional suppliers. See the peptide legality guide for how this works in practice.
What is the typical dose of TA-1?
The standard research dose is 1.5 mg subcutaneous, twice per week. Clinical hepatitis protocols use 1.6 mg twice weekly. Some acute protocols use 0.45 mg daily for 2-4 weeks. Underdosing at 200-500 mcg is a common mistake and unlikely to produce meaningful immune effects.
How is TA-1 different from TB-500?
They are completely different peptides despite both containing "thymo" in the name. TB-500 (Thymosin Beta-4) is a healing peptide for tissue repair. TA-1 (Thymosin Alpha-1) is an immune modulating peptide. Different mechanisms, different uses. See TB-500 for the healing peptide.
Does TA-1 cause immune suppression?
No. TA-1 is an immune modulator, not an immune suppressant. It enhances and regulates immune function rather than suppressing it. This is why it is contraindicated for transplant patients on immunosuppressants, because it would work against their medication.
How long does a TA-1 cycle last?
Most research protocols run 4 to 12 weeks depending on the goal. Clinical hepatitis treatment runs 6 to 12 months. Continuous use without breaks is generally not recommended for wellness users. Many people cycle seasonally or during periods of increased immune challenge.
Can I stack TA-1 with other peptides?
Yes. TA-1 stacks well with longevity protocols. It pairs naturally with NAD+ therapy for cellular health. It does not interact with healing peptides like BPC-157, so they can be used concurrently if needed.
Where can I buy TA-1 in the Philippines?
Most expats source research-grade TA-1 from regional peptide suppliers with cold-chain shipping to Philippines. Zadaxin is not commonly available at local pharmacies. Check the supply index for verified sources. Always verify batch purity with a third-party COA.
Where to get Thymosin Alpha-1 in the Philippines
See our community-verified supplier list with COA verification and cold-chain shipping to the Philippines.
Risk · Disclosure · Editorial Status
This page is editorial information for adults researching peptide therapy. It is not medical advice, not a prescription, and not an endorsement of any specific product, supplier, or protocol. Side effects can be serious and individual response varies. Talk to a licensed physician — ideally one with peptide-specific clinical experience — before starting any compound, adjusting a dose, or discontinuing therapy.
In the Philippines, GLP-1 medications are prescription-only under FDA Philippines regulation. Research-grade peptides occupy a regulatory gray area: import for personal research use is generally tolerated, but the Bureau of Customs reserves the right to inspect and detain shipments. Do not import for resale.
Editorial Status
Independent · Non-clinical
Affiliation
Not a clinic · Not a pharmacy
Last Updated
—
↗ Related peptides